Comparison of Her-2, EGFR and Cyclin D1 in Primary Breast Cancer and Paired Metastatic Lymph Nodes: An Immunohistochemical and Chromogenic In Situ Hybridization Study

The significant advance in the development of molecular-targeting drugs has made an evaluation of Her-2, EGFR, and cyclin D1 an important clinical issue in breast cancer patients. This study compared the Her-2, EGFR, and cyclin D1 status of primary tumors as well as their matching lymph node metasta...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Eun Yoon, Han, Jae Joon, Choi, Yoon-La, Kim, Kyoung-Mee, Oh, Young Lyun
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2610643/
https://www.ncbi.nlm.nih.gov/pubmed/19119452
http://dx.doi.org/10.3346/jkms.2008.23.6.1053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2610643/
https://www.ncbi.nlm.nih.gov/pubmed/19119452
http://dx.doi.org/10.3346/jkms.2008.23.6.1053

Ejemplares similares